Skip to content

Eating behaviour in craniopharyngioma

Evaluating eating behaviours, energy homeostasis and obesity in childhood craniopharyngioma: A feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN86005167
Enrollment
20
Registered
2019-04-10
Start date
2019-01-25
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniopharyngioma Cancer

Interventions

No intervention in this study. It is a feasibility study measuring eating behaviour, appetite, functional magnetic resonance imaging (cerebral blood flow, response to food cues and resting brain netwo

Sponsors

University of Bristol
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged between 7-25 years who have a diagnosis of craniopharyngioma

Exclusion criteria

Exclusion criteria: 1. Clinically unwell requiring hospital or intensive treatment 2. Unwilling to fast 3. Patients for whom it would be unsafe to have an MRI including those with: 3.1 Certain metal implants 3.2 Tattoos with metallic ink 3.3 Metal body piercings which cannot be removed 4. Pregnancy to avoid harm to the foetus 5. Claustrophobia in the closed MRI environment or unable to tolerate the MRI scanner 6. Weight above 152kg and/or girth greater than 210cm due to size limitations of MRI scanner

Design outcomes

Primary

MeasureTime frame
1. Characterisation of the severity of the tumour, treatment and pituitary dysfunction in the studied craniopharyngioma patient population. Assessed using a proforma and medical notes once patient recruited into the study. 2. Feasibility outcome (i) can sufficient patient numbers can be recruited (number recruited compared to number on clinic database). 3. Feasibility outcome (ii) patient tolerability of the number and nature of measures used in the study. Measure by an acceptability questionnaire at the end of the study session. 4. Preliminary data on the following: (i) functional MRI (using arterial spin labelling and BOLD fMRI scans), (ii) indirect calorimetry to measure resting metabolic rate, (iii) ad libitum food consumption (food choice and portion size), (iv) oral glucose tolerance test, measuring glucose, insulin, PYY, ghrelin, GLP-1 (5 time-points before and 30, 60, 90 and 120 post-glucose). (iv) Leptin will also be measured at baseline as well as a full blood count (FBC) and electrolytes (U&Es). (v) Appetite ratings are also given at the same timepoints during the OGTT.

Secondary

MeasureTime frame
1. Quality of life questionnaire (age appropriate) measured once using the MMQL. 2. Hyperphagic eating behaviour questionnaire 3. Adult or Child eating behaviour questionnaire 4. Body composition measured using multifrequency bioelectrical impedance, Tanita MC-780), to give fat-free mass and fat mass, and total body water

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026